Key result
SADI-S shows no benefit over sleeve gastrectomy for weight trajectories or metabolic profiles.
Why the study?
The stepwise approach of performing sleeve gastrectomy first in SADI-S patients provides an opportunity to disentangle weight loss mechanisms triggered by each component.
Does SADI-S improve weight loss and metabolic responses compared to SG alone in patients with obesity class 3?
Cohort (n=14)
No
Does SADI-S improve weight loss and metabolic responses compared to SG alone in patients with obesity class 3?
The restrictive component (sleeve gastrectomy) appears to be the primary driver of weight loss and metabolic improvements in the first 12 months, supporting a two-step surgical approach for safety.
Stepwise SADI-S may isolate SG versus bypass effects on weight and hormones; leaves open mechanisms and practice implications.
INTRODUCTION: Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) is a restrictive/hypoabsorptive procedure recommended for patients with obesity class 3. For safety reasons, SADI-S can be split into a two-step procedure by performing a sleeve gastrectomy (SG) first. This stepwise approach also provides an unprecedented opportunity to disentangle the weight loss mechanisms triggered by each component. The objective was to compare weight trajectories and post-prandial endocrine and metabolic responses of patients with obesity class 3 submitted to SADI-S or SG as the first step of SADI-S. METHODS: Subjects submitted to SADI-S (n = 7) or SG (n = 7) at a tertiary referral public academic hospital underwent anthropometric evaluation and a liquid mixed meal tolerance test (MMTT) pre-operatively and at 3, 6, and 12 months post-operatively. RESULTS: Anthropometric parameters, as well as metabolic and micronutrient profiles, were not significantly different between groups, neither before nor after surgery. There were no significant differences in fasting or post-prandial glucose, insulin, C-peptide, ghrelin, insulin secretion rate, and insulin clearance during the MMTT between subjects submitted to SADI-S and SG. There was no lost to follow-up. CONCLUSIONS: The restrictive component seems to be the main driver for weight loss and metabolic adaptations observed during the first 12 months after SADI-S, given that the weight trajectories and metabolic profiles do not differ from SG. These data provide support for surgeons' choice of a two-step SADI-S without jeopardizing the weight loss outcomes.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2024) conducted a cohort in Obesity class 3 (n=14). Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) vs. Sleeve gastrectomy (SG) was evaluated on Weight trajectories and post-prandial endocrine and metabolic responses. SADI-S (n=7) resulted in no significant differences in weight trajectories or metabolic profiles compared to sleeve gastrectomy (n=7) over 12 months of follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: